Zhu S, Lin S, Han R
Pharmaceutics. 2024; 16(9).
PMID: 39339173
PMC: 11435246.
DOI: 10.3390/pharmaceutics16091135.
Papouliakos S, Chrysovergis A, Papanikolaou V, Spyropoulou D, Papanastasiou G, Asimakopoulos A
Maedica (Bucur). 2024; 19(2):355-359.
PMID: 39188831
PMC: 11345059.
DOI: 10.26574/maedica.2024.19.2.355.
Zhang H, Li Q, Guo X, Wu H, Hu C, Liu G
J Pharm Anal. 2024; 14(6):100950.
PMID: 39027911
PMC: 11255892.
DOI: 10.1016/j.jpha.2024.02.004.
Meza-Espinoza J, Gonzalez-Garcia J, Nieto-Marin N, Patron-Baro L, Gonzalez-Arreola R, Arambula-Meraz E
Mol Cytogenet. 2024; 17(1):17.
PMID: 39020403
PMC: 11256661.
DOI: 10.1186/s13039-024-00686-0.
Taha M, Ahmadian M
Biomolecules. 2024; 14(4).
PMID: 38672417
PMC: 11047961.
DOI: 10.3390/biom14040399.
Baseline unfolded protein response signaling adjusts the timing of the mammalian cell cycle.
Chowdhury S, Solley S, Polishchuk E, Bacal J, Conrad J, Gardner B
Mol Biol Cell. 2024; 35(6):br12.
PMID: 38656789
PMC: 11238080.
DOI: 10.1091/mbc.E23-11-0419.
Updated Review Article: Cyclin-Dependent Kinase 4/6 Inhibitor Impact, FDA Approval, and Resistance Pathways.
Hunter R, Park J, Asprer K, Doan A
J Pharm Technol. 2023; 39(6):298-308.
PMID: 37974598
PMC: 10640864.
DOI: 10.1177/87551225231205153.
Human cells experience a Zn pulse in early G1.
Rakshit A, Holtzen S, Lo M, Conway K, Palmer A
Cell Rep. 2023; 42(6):112656.
PMID: 37330912
PMC: 10592493.
DOI: 10.1016/j.celrep.2023.112656.
Epigallocatechin Gallate (EGCG), an Active Phenolic Compound of Green Tea, Inhibits Tumor Growth of Head and Neck Cancer Cells by Targeting DNA Hypermethylation.
Agarwal A, Kansal V, Farooqi H, Prasad R, Singh V
Biomedicines. 2023; 11(3).
PMID: 36979768
PMC: 10045148.
DOI: 10.3390/biomedicines11030789.
Cell cycle exits and U-turns: Quiescence as multiple reversible forms of arrest.
Johnson M, Cook J
Fac Rev. 2023; 12:5.
PMID: 36923701
PMC: 10009890.
DOI: 10.12703/r/12-5.
G2/M checkpoint regulation and apoptosis facilitate the nuclear egress of parvoviral capsids.
Mattola S, Mantyla E, Aho V, Salminen S, Leclerc S, Oittinen M
Front Cell Dev Biol. 2022; 10:1070599.
PMID: 36568985
PMC: 9773396.
DOI: 10.3389/fcell.2022.1070599.
Factor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteins.
Yunes S, Willoughby J, Kwan J, Biagi J, Pokharel N, Chin H
PLoS One. 2022; 17(6):e0268857.
PMID: 35704642
PMC: 9200292.
DOI: 10.1371/journal.pone.0268857.
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies.
Bruno S, Luserna di Rora A, Napolitano R, Soverini S, Martinelli G, Simonetti G
J Exp Clin Cancer Res. 2022; 41(1):159.
PMID: 35490245
PMC: 9055704.
DOI: 10.1186/s13046-022-02363-9.
Maternal Low-Protein Diet Deregulates DNA Repair and DNA Replication Pathways in Female Offspring Mammary Gland Leading to Increased Chemically Induced Rat Carcinogenesis in Adulthood.
Zapaterini J, Fonseca A, Bidinotto L, Colombelli K, Rossi A, Kass L
Front Cell Dev Biol. 2022; 9:756616.
PMID: 35178394
PMC: 8844450.
DOI: 10.3389/fcell.2021.756616.
Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.
Mitra T, Elangovan S
Mol Cell Biochem. 2021; 476(12):4363-4385.
PMID: 34453645
DOI: 10.1007/s11010-021-04249-4.
USP7 limits CDK1 activity throughout the cell cycle.
Galarreta A, Valledor P, Ubieto-Capella P, Lafarga V, Zarzuela E, Munoz J
EMBO J. 2021; 40(11):e99692.
PMID: 33856059
PMC: 8167359.
DOI: 10.15252/embj.201899692.
The Significance of Targeting Poly (ADP-Ribose) Polymerase-1 in Pancreatic Cancer for Providing a New Therapeutic Paradigm.
Jeong K, Park M
Int J Mol Sci. 2021; 22(7).
PMID: 33805293
PMC: 8037971.
DOI: 10.3390/ijms22073509.
The fission yeast S-phase cyclin Cig2 can drive mitosis.
Pickering M, Magner M, Keifenheim D, Rhind N
Genetics. 2021; 217(1):1-12.
PMID: 33683349
PMC: 8045716.
DOI: 10.1093/genetics/iyaa002.
The biological mechanism involved in anticancer properties of amniotic membrane.
Jafari A, Niknejad H, Rezaei-Tavirani M, Zali H
Oncol Rev. 2020; 14(1):429.
PMID: 32153725
PMC: 7036708.
DOI: 10.4081/oncol.2020.429.
Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition.
van Harten A, de Boer D, Martens-de Kemp S, Buijze M, Ganzevles S, Hunter K
Sci Rep. 2020; 10(1):2330.
PMID: 32047167
PMC: 7012863.
DOI: 10.1038/s41598-020-58509-2.